Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Axel Hauschild et al.|European Journal of Cancer|2017Cited by 284
Genome-wide association study identifies three new melanoma susceptibility lociJennifer H. Barrett, Joan Anton Puig‐Butille, David L. Duffy et al.|Nature Genetics|2011Cited by 250
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanomaMatthew H. Law, Graham J. Mann, D. Timothy Bishop et al.|Nature Genetics|2015Cited by 245
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset‐Séguin, Johan Hansson, Axel Hauschild et al.|The Lancet Oncology|2015Cited by 244
Common sequence variants on 20q11.22 confer melanoma susceptibilityNicholas K. Hayward, Stuart MacGregor, Grant W. Montgomery et al.|Nature Genetics|2008Cited by 226